EGFR-mutated lung cancer: a paradigm of molecular oncology.

Oncotarget

Volumn 1, Issue 7, 2010, Pages 497-514

  Zhang, Zhenfeng ^a   Stiegler, Amy L ^b   Boggon, Titus J ^b   Kobayashi, Susumu ^b   Halmos, Balazs ^b  

^a New York Presbyterian Hospital Columbia University Medical Center

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; MUTANT PROTEIN; PROTEIN KINASE INHIBITOR;

ANIMAL; BIOLOGICAL MODEL; CARCINOMA; DRUG ANTAGONISM; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; METHODOLOGY; MOLECULAR DIAGNOSIS; MOLECULARLY TARGETED THERAPY; ONCOLOGY; REVIEW; STANDARD;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA; HUMANS; LUNG NEOPLASMS; MEDICAL ONCOLOGY; MODELS, BIOLOGICAL; MOLECULAR DIAGNOSTIC TECHNIQUES; MOLECULAR TARGETED THERAPY; MUTANT PROTEINS; PROTEIN KINASE INHIBITORS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 79958020132     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.186     Document Type: Review

References (0)